TOP TIERMARKET NEWSWIRE
News & sentiment

STOKE THERAPEUTICS I (STOK) — News & AI sentiment

STOKE THERAPEUTICS I (STOK) news roundup. 1 story in the past week, 8 over 30 days. Average 30-day sentiment is 59/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 6 sales totalling $899K — net selling of $899K. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
1
avg sentiment 50/100
30d stories
8
avg sentiment 59/100
Insider net (90d)
$899K
0 buys · 6 sells
Congress (90d)
0
0 buys · 0 sells

STOK news in the last 24 hours, 7 days, 30 days and 90 days

How much STOK coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowSTOK storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days150/100STOK headlines →
Last 30 days859/100STOK headlines →
Last 90 days3657.4/100STOK headlines →

Latest stories on STOK

6d ago
Oct 19
Oct 16
Oct 12
Oct 12
Oct 6
Oct 6
Oct 5
Sep 25
Sep 23
Sep 23
Sep 16
Sep 10
Sep 3
Sep 3
Sep 3
Sep 2
Sep 1
Sep 1
Sep 1
Sep 1
Aug 21
Aug 21
Aug 21
Why is Stoke Therapeutics stock gaining today?
Investing.com Markets50 · neutralgeneral
Aug 21
Open STOK in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →